Prapela, Inc

Concord,  MA 
United States
  • Booth: 131

For NAS, Prapela offers Stochastic Vibrotactile Stimulation.

Prapela is introducing Stochastic Vibrotactile Stimulation (SVS) to improve the clinical course of newborns with neonatal abstinence syndrome (NAS).  SVS is a gentle random vibration, clinically proven to replace irregular breathing and heart rates with healthy, rhythmic rates which helps console NAS newborns.  Developed and evaluated for ten years at Harvard’s Wyss Institute, UMass Memorial Medical Center and Massachusetts General Hospital, our SVS pad placed in a hospital bassinet is non-habit forming and does not interrupt sleep cycles.  We are also introducing our baby box with and without SVS.

Prapela has won several awards including:  $200,000 from the Ohio Opioid Technology Challenge (9/12/18), $10,000 from the NIDA Substance Use Disorder Challenge (2/7/18), $75,000 from Johnson & Johnson’s Next-Gen Baby Box QuickFire Challenge (11/30/17) and $25,000 from the FDA funded 5th Annual Pediatric Device Innovation Symposium sponsored by Children’s National Health System (9/24/17).

Brands: Prapela is introducing three new products, the Prapela SVS hospital bassinet, Prapela SVS baby box and the Prapela baby box.

For technical assistance, please contact support.